Thyrocare Reports Strong Q2FY26 Results – Revenue Up 22%, PAT Up 82%; Board Declares 2:1 Bonus and ₹7 Interim Dividend
Thyrocare Technologies reported a solid Q2FY26 with 22% YoY revenue growth and 82% jump in PAT. The Board declared a 2:1 bonus issue and ₹7 interim dividend, celebrating 25 years of the company. The diagnostic major processed 53.3 million tests this quarter, up 21% YoY.